Regulating antimicrobial use within hospitals: A qualitative study.

Accreditation Antimicrobial resistance Antimicrobial stewardship Qualitative research Regulation

Journal

Infection, disease & health
ISSN: 2468-0869
Titre abrégé: Infect Dis Health
Pays: Netherlands
ID NLM: 101689703

Informations de publication

Date de publication:
11 Jan 2024
Historique:
received: 03 04 2023
revised: 30 11 2023
accepted: 06 12 2023
medline: 13 1 2024
pubmed: 13 1 2024
entrez: 12 1 2024
Statut: aheadofprint

Résumé

To examine how regulatory structures and processes focused on antimicrobial stewardship and antimicrobial resistance are experienced by hospital managers and clinicians. Forty-two hospital managers and clinicians working within accreditation and antimicrobial stewardship teams in three Australian hospitals participated in individual in-depth interviews. Thematic analysis was performed. Thematic analysis revealed participants' experiences of hospital antimicrobial regulation and their perceptions of what would be required for meaningful antimicrobial optimisation. Theme 1: Experience of regulation of antimicrobials within hospitals: Participants described an increased profile of antimicrobial resistance with inclusion in regulatory requirements, but also the risks of bureaucratic manoeuvring to meet standards rather than governance-inducing systemic changes. Theme 2: Growth of accreditation processes and hospitals over time: Both regulatory requirements and hospitals were described as evolving over time, each manoeuvring in response to each other (e.g. development of short notice accreditation). Theme 3: Perceived requirements for change: Participants perceived a need for top-down buy-in, resource prioritisation, complex understanding of power and influence on clinician behaviour, and a critical need for medical engagement. This study around antimicrobials shows the tension and dynamic relationship between regulatory processes and hospital responses, bringing to light the enduring balance of a system that positions itself to meet regulatory requirements and emerging "demands", without necessarily addressing the key underlying concerns. Antimicrobial resistance-related solutions are perceived as likely to require further resourcing and buy-in across multiple levels, engagement across professional streams and require strategies that consider complex systems change in order for regulatory structures to have potency.

Identifiants

pubmed: 38216402
pii: S2468-0451(23)00112-8
doi: 10.1016/j.idh.2023.12.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.

Auteurs

Jennifer Broom (J)

Sunshine Coast University Hospital, Sunshine Coast Hospital and Health Service, 6 Doherty Street, Birtinya, QLD, Australia; University of Queensland, Brisbane, QLD, Australia. Electronic address: jennifer.broom@health.qld.gov.au.

Alex Broom (A)

Sydney Centre for Healthy Societies, School of Social and Political Sciences, The University of Sydney, Camperdown, NSW, Australia. Electronic address: alex.broom@sydney.edu.au.

Katherine Kenny (K)

Sydney Centre for Healthy Societies, School of Social and Political Sciences, The University of Sydney, Camperdown, NSW, Australia. Electronic address: Katherine.kenny@sydney.edu.au.

Pamela Konecny (P)

Department of Infectious Diseases, Immunology & Sexual Health, St George Hospital, Kogarah, Sydney, Australia; School of Clinical Medicine, University of New South Wales, Sydney, Australia. Electronic address: pam.konecny@health.nsw.gov.au.

Jeffrey J Post (JJ)

School of Clinical Medicine, University of New South Wales, Sydney, Australia; Department of Infectious Diseases, Prince of Wales Hospital and Community Health Services, Randwick, NSW, Australia. Electronic address: jeffrey.post@health.nsw.gov.au.

Classifications MeSH